Clinical Trial Update: Observational Open Study of Polyoxidonium in Hospitalized Patients With COVID-19

View source ↗

Summary

Observational open-label study of Polyoxidonium in hospitalized COVID-19 patients has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Disease 2019

Drugs mentioned

• Polyoxidonium

Snippet

Sponsor: NPO Petrovax | Conditions: Infections, Coronavirus | Status: COMPLETED | Results posted: 2020-12-03